Request Deal Involvement
Senti Biosciences went public via merger with Dynamics Special Purpose in a $601m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Goodwin Procter
financial advisors
Bank of America
financial advisors
Morgan Stanley
legal advisors to financial advisors
Latham & Watkins
legal advisors
Davis Polk & Wardwell
financial advisors
JP Morgan
financial advisors
Bank of America
or
Principals
target
SENTI BIOSCIENCES
bidder
DYNAMICS SPECIAL PURPOSE CORPORATION
bidder
8VC (EIGHT PARTNERS LLC)
bidder
AMGEN VENTURES
bidder
COUNTERPOINT GLOBAL - MORGAN STANLEY
bidder
THE INVUS GROUP LLC
bidder
LIFEFORCE CAPITAL
bidder
NEW ENTERPRISE ASSOCIATES (NEA)
bidder
T. ROWE PRICE GROUP INC
bidder
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite